As of 3:59pm ET
| +0.02 / +0.65%|
The 2 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +45.63% increase from the last price of 3.09.
The current consensus among 3 polled investment analysts is to Hold stock in Sunesis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.